Jo Bhakdi is the founder and CEO of Quantgene. His work in machine learning, sequencing technology and DNA extraction procedures defines the cutting edge of genomic diagnostics, early disease detection and precision medicine.
Prior to Quantgene, Jo founded i2X, an investment framework that composes low-risk Venture Capital portfolios across large numbers of technology startups. The i2X platform laid important foundations for advanced analytics in both financial and biotechnology applications, such as the Quantgene machine learning platform.
Bhakdi holds a Masters in Economics and Psychology from Tubingen University, one of Germany’s leading academic institutions, with a focus on financial theory and statistics. He started his career at WPP and Omnicom where he held Strategy and Executive Director positions.
Beyond his focus on technology and the future of medicine, Bhakdi is dedicated to bringing the brightest, pioneering minds together, to push the boundaries of health, life and innovation for all.
Dr. Gómez performs R&D on Quantgene's pattern recognition challenges. His has extensive expertise in machine learning, statistics and software development.
Prior to his work at Quantgene Dr. Gómez was a Researcher at the University Hospital Erlangen where he conceived, developed and implemented several deep learning approaches for processing high-speed for the diagnosis and treatment of voice disorders. Additionally he initiated and coordinated an international collaboration to create the largest high-speed videoendoscopy dataset publicly available.
Dr. Gómez received his PhD from the Friedrich-Alexander-University Erlangen-Nuremberg. He holds a M.Sc. and B.Sc. in computer science from the Technical University Munich.
Monika E. Hagen, MD, MBA is the Chief Medical Officer of Quantgene and a board certified General Surgeon, specializing in bariatric surgery. Trained in Germany, Switzerland and the United States, she has over a decade of experience as a medical doctor, academic surgeon, teacher, medical device expert and clinical trial specialist. She also received her MBA from the University of Wales in Cardiff, UK.
Dr. Hagen is an international thought leader and lecturer in bariatric and minimally invasive surgery, as well as surgical robotic technology and its clinical applications. She is a frequent speaker at medical conferences and has published extensively on topics ranging from robotic surgery, to clinical trial design and the future of medicine.
Prior to joining Quantgene, she utilized her clinical, strategic planning, and business development expertise, serving as a regular consultant to financial, technology, medical and biotech companies. Dr. Hagen divides her time between professional roles in Geneva, Switzerland, Silicon Valley and Santa Monica, California.
Dave Herrmann is Chief Commercial Officer at Quantgene. Previously he was global head of Digital Solutions at Johnson & Johnson. Dave has experience developing AI for surgeries. He has led product marketing for multiple billion dollar companies.
Dr. Ilia Ichetovkin, Ph.D. is the Chief Scientific Officer at Quantgene. Before joining Quantgene, he spent 20 years at several biotech companies developing and commercializing highly complex diagnostic products in the areas of molecular oncology and metabolic diseases. His experience spans from CLIA laboratory operations to successful regulatory submissions of IVD and CDx products. He has worked as VP of Diagnostic Strategies at Rhythm Pharmaceuticals, Head of Oncology R&D at Vela Diagnostics, as Head of Clinical Diagnostics and Biomarker Development at Celgene/Abraxis,and as Director of U.S. Laboratory Operations with LabCorp Clinical Trials.
Dr. Ichetovkin has a Ph.D. in Biomedical Sciences from Albert Einstein College of Medicine and M.S. in chemistry from Moscow State University.
Timothy is Chief Technology Officer at Quantgene. He is an innovator and creative team leader with a track record of launching world-class products and platforms that drive innovation and pushing boundaries in new markets. He is passionate about connecting computational and physical space through technology. Timothy’s experience spans from startups to Fortune 500 companies. He has over 18 years of commercial software experience and 12 years leading large teams across complex organizations. Members of his team have gone on to become technology leaders at Google, Facebook, Amazon and Twitter. His previous experience includes, co-creator of HBOGO, and VP of Technology at Comcast/NBCU.